• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?

作者信息

Caine Graham J, Lip Gregory Y H

出版信息

Arch Intern Med. 2003 May 26;163(10):1243-4; author reply 1244. doi: 10.1001/archinte.163.10.1243-b.

DOI:10.1001/archinte.163.10.1243-b
PMID:12767973
Abstract
摘要

相似文献

1
Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?低分子量肝素在癌症患者静脉血栓栓塞症二级预防中比华法林更安全吗？
Arch Intern Med. 2003 May 26;163(10):1243-4; author reply 1244. doi: 10.1001/archinte.163.10.1243-b.
2
International normalized ratio and anticoagulation.国际标准化比值与抗凝
Arch Intern Med. 2003 May 26;163(10):1242-3; author reply 1244. doi: 10.1001/archinte.163.10.1242-c.
3
Apparent warfarin potency inconsistencies compromise effectiveness.华法林的实际效价不一致会影响其疗效。
Arch Intern Med. 2003 May 26;163(10):1243; author reply 1244. doi: 10.1001/archinte.163.10.1243-a.
4
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.低分子量肝素与华法林用于癌症患者静脉血栓栓塞症二级预防的比较：一项随机对照研究。
Arch Intern Med. 2002;162(15):1729-35. doi: 10.1001/archinte.162.15.1729.
5
Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.低分子量肝素在癌症相关血栓形成中的应用：治疗、二级预防及生存情况
J Oncol Pharm Pract. 2007 Jun;13(2):85-97. doi: 10.1177/1078155207079169.
6
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.癌症患者静脉血栓栓塞的治疗：Matisse临床试验的亚组分析
Thromb Haemost. 2009 Apr;101(4):762-9.
7
Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?低分子量肝素与口服抗凝剂治疗有症状静脉血栓栓塞症的长期疗效比较：癌症相关死亡率是否存在差异？
J Clin Oncol. 2005 Oct 1;23(28):7248-50; author reply 7250. doi: 10.1200/JCO.2005.01.7897.
8
Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.低分子量肝素或口服抗凝剂用于癌症患者深静脉血栓形成的二级预防。
Semin Thromb Hemost. 2003 Dec;29 Suppl 1:9-11. doi: 10.1055/s-2003-45410.
9
Thromboembolism.血栓栓塞
Clin Evid. 2002 Jun(7):199-213.
10
[Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
MMW Fortschr Med. 2003 May 8;145(19):suppl 3-4.